Matthew Smith, MD
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $975 and has fallen 64.9% since, to $342 in 2025.
Across 68 payments — averaging $64.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$841
- AstraZeneca$801
- Abbott$421
- SK Life Science, Inc.$415
- UCB, Inc.$406
- Johnson & Johnson$249
- plus $1K from 16 others
Across 3 payments — averaging $68,083 each. An ownership or investment interest held by the physician or an immediate family member.
- Vesalio, Inc.$204K
What the payments were for
- Food & beverage$4,383100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $841 |
| AstraZeneca(2 entities) | 8 | $801 |
| Abbott | 3 | $421 |
| SK Life Science, Inc. | 6 | $415 |
| UCB, Inc. | 19 | $406 |
| Johnson & Johnson | 2 | $249 |
| Pfizer | 4 | $170 |
| GSK | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Neurelis, Inc. | 1 | $121 |
| Mylan Specialty L.p. | 1 | $121 |
| Silk Road Medical, Inc. | 1 | $121 |
| Jazz Pharmaceuticals Inc. | 1 | $108 |
| E.r. Squibb & Sons, L.L.C. | 3 | $103 |
| Teleflex LLC | 3 | $67 |
| Genentech USA, Inc. | 2 | $50 |
| Stryker | 1 | $43 |
| Baxter Healthcare | 1 | $25 |
| Vapotherm Inc | 1 | $23 |
| Sanofi | 1 | $21 |
| Ambu Inc. | 1 | $16 |
| Acell, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XCOPRI$372
- JOT DX$289
- LINQ II$271
- ULTOMIRIS$256
- XARELTO$249
- Pipeline$233
- Abre$192
- AMPLATZER Occluders$132
- ANORO$125
- ELIQUIS$125
- ANDEXXA$125
- FASENRA$125
- LOKELMA$125
- AJOVY$122
- Yupelri$121
- ENROUTE Transcarotid Neuroprotection System$121
- ENROUTE Transcarotid Stent System$121
- ENHANCE Transcarotid Peripheral Access Kit$121
- ENROUTE 0.014 Guidewire$121
- SOLIRIS$112
How this compares
$4,383 in reported general payments places this provider in the 65th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Topiramate | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other neurology in Macon
- Sudhir AthniMacon$432K
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- John MorganAugusta$715K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Dinesh RajuLawrenceville$414K
- Victor RosenfeldSavannah$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.